Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,520 papers from all fields of science
Search
Sign In
Create Free Account
ARC111
Known as:
ARC-111
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
topovale
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
High-Dimensional Descriptor Selection and Computational QSAR Modeling for Antitumor Activity of ARC-111 Analogues Based on Support Vector Regression (SVR)
W. Zhou
,
Zhijun Dai
,
Yuan Chen
,
Haiyan Wang
,
Zheming Yuan
International Journal of Molecular Sciences
2012
Corpus ID: 7402027
To design ARC-111 analogues with improved efficiency, we constructed the QSAR of 22 ARC-111 analogues with RPMI8402 tumor cells…
Expand
2012
2012
Computational QSAR models with high-dimensional descriptor selection improve antitumor activity design of ARC-111 analogues
Wei Zhou
,
Zhijun Dai
,
Yuan Chen
,
Zheming Yuan
Medicinal Chemistry Research
2012
Corpus ID: 253645505
ARC-111 has potent topoisomerase I-targeting activity and pronounced antitumor activity. To design ARC-111 analogues with…
Expand
2010
2010
Comparative QSAR modeling of antitumor activity of ARC-111 analogues using stepwise MLR, PLS, and ANN techniques
Yanjun Yu
,
R. Su
,
Libing Wang
,
W. Qi
,
Zhimin He
Medicinal Chemistry Research
2010
Corpus ID: 25235231
Dibenzo [c,h]-[1,6] naphthyridin-6-one (ARC-111) and its analogues can exhibit potent topoisomerase I targeting and antitumor…
Expand
2008
2008
Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors
L. Kurtzberg
,
T. Battle
,
+12 authors
B. Teicher
Molecular Cancer Therapeutics
2008
Corpus ID: 17723100
Topoisomerase I (TopoI), an established anticancer target, is an enzyme producing a single-strand DNA break during transcription…
Expand
2008
2008
Facile formation of hydrophilic derivatives of 5H-8,9-dimethoxy-5-[2-(N,N-dimethylamino)ethyl]-2,3-methylenedioxydibenzo[c,h] [1,6]naphthyridin-6-one (ARC-111) and its 12-aza analog via quaternary…
Wei Feng
,
M. Satyanarayana
,
Y. Tsai
,
Angela A. Liu
,
Leroy F. Liu
,
E. LaVoie
Bioorganic & Medicinal Chemistry Letters
2008
Corpus ID: 206236694
2007
2007
ARC-111 inhibits hypoxia-mediated hypoxia-inducible factor-1alpha accumulation.
F. Meng
,
Xuan-Thao Nguyen
,
Xiaohong Cai
,
Jianxin Duan
,
M. Matteucci
,
C. Hart
Anti-Cancer Drugs
2007
Corpus ID: 25791410
ARC-111, a small-molecule topoisomerase I inhibitor, is a potent cytotoxic drug against multiple human cancer cell lines under…
Expand
2006
2006
6-Substituted 6H-dibenzo[c,h][2,6]naphthyridin-5-ones: reversed lactam analogues of ARC-111 with potent topoisomerase I-targeting activity and cytotoxicity.
Shejin Zhu
,
Alexander L. Ruchelman
,
Nai Zhou
,
Angela A. Liu
,
Leroy F. Liu
,
E. LaVoie
Bioorganic & Medicinal Chemistry
2006
Corpus ID: 36220046
2006
2006
Characterization of ARC-111 as a TOP 1/HIF 1α inhibitor.
F. Meng
,
Xuan-Thao Nguyen
,
Xiaohong Cai
,
Jianxin Duan
,
M. Matteucci
,
C. Hart
2006
Corpus ID: 82789561
Proc Amer Assoc Cancer Res, Volume 47, 2006 5540 The hypoxia-inducible factor-1 (HIF-1) transcription factor is an essential…
Expand
2005
2005
Esters and amides of 2,3-dimethoxy-8,9-methylenedioxy-benzo[i]phenanthridine-12-carboxylic acid: potent cytotoxic and topoisomerase I-targeting agents.
Shejin Zhu
,
Alexander L. Ruchelman
,
Nai Zhou
,
Angela A. Liu
,
Leroy F. Liu
,
E. LaVoie
Bioorganic & Medicinal Chemistry
2005
Corpus ID: 8079218
Highly Cited
2003
Highly Cited
2003
Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug.
Tsai-Kun Li
,
P. Houghton
,
+6 authors
Leroy F. Liu
Cancer Research
2003
Corpus ID: 10259216
8,9-Dimethoxy-5-(2-N,N-dimethylaminoethyl)-2,3-methylenedioxy-5H-dibenzo[c,h][1,6] naphthyridin-6-one (ARC-111, topovale) is a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE